The Patent Finder

Almac Diagnostics Limited

Also on record
Records under this name other than patents Almac Diagnostics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Almac Diagnostics Limited

PatentTitleStatus Expires Confidence
US 9,677,140Molecular diagnostic test for cancer
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,670,547Molecular diagnostic test for cancer
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,378,066Molecular diagnostic test for cancer
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,214,777Molecular diagnostic test for cancer
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,254,986Gene signature for immune therapies in cancer
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,091,809Molecular diagnostic test for cancer
Lapsed on the fee record
Ended Aug 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 17, 2025From the USPTO record
US 10,280,468Molecular diagnostic test for predicting response to anti-angiogenic drugs and prognosis of cancer
Formerly held
Lapsed on the fee record
Ended May 7, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 7, 2023From the USPTO record
US 10,260,097Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
Formerly held
Lapsed on the fee record
Ended Apr 16, 2023 · High confidence
Lapsed on the fee recordEnded Apr 16, 2023High confidence
US 10,196,691Colon cancer gene expression signatures and methods of use
Formerly held
Lapsed on the fee record
Ended Feb 5, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 5, 2023From the USPTO record
US 10,196,697Prostate cancer classification
Formerly held
Lapsed on the fee record
Ended Feb 5, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 5, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited